Financial Metrics

ASTH Astrana Health, Inc.

Range: 2016-01-01 to 2026-04-29

Export Quarterly CSV Export Annual CSV

Chart Range:

% Change:

Annual View:

Financial Statements

Grouped by statement

Income Statement

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2017-03-31	0.15	—	USD/shares	10-Q	2018-05-15
Quarterly	2017-06-30	0.07	-53.3%	USD/shares	10-Q	2018-08-14
Quarterly	2017-09-30	0.2	+185.7%	USD/shares	10-Q	2018-11-14
Quarterly	2018-03-31	0.06	-70.0%	USD/shares	10-Q	2019-05-10
Quarterly	2018-06-30	0.07	+16.7%	USD/shares	10-Q	2019-08-09
Quarterly	2018-09-30	0.24	+242.9%	USD/shares	10-Q	2019-11-08
Quarterly	2019-03-31	0.0	-100.0%	USD/shares	10-Q	2020-05-29
Quarterly	2019-06-30	0.09	—	USD/shares	10-Q	2020-08-10
Quarterly	2019-09-30	0.1	+11.1%	USD/shares	10-Q	2020-11-09
Quarterly	2020-03-31	0.11	+10.0%	USD/shares	10-Q	2021-05-07
Quarterly	2020-06-30	0.19	+72.7%	USD/shares	10-Q	2021-08-06
Quarterly	2020-09-30	0.45	+136.8%	USD/shares	10-Q	2021-11-05
Quarterly	2021-03-31	0.3	-33.3%	USD/shares	10-Q	2022-05-10
Quarterly	2021-06-30	0.28	-6.7%	USD/shares	10-Q	2022-08-09
Quarterly	2021-09-30	0.74	+164.3%	USD/shares	10-Q	2022-11-07
Quarterly	2022-03-31	0.3	-59.5%	USD/shares	10-Q/A	2023-08-09
Quarterly	2022-06-30	0.26	-13.3%	USD/shares	10-Q	2023-08-09
Quarterly	2022-09-30	0.5	+92.3%	USD/shares	10-Q	2023-11-09
Quarterly	2023-03-31	0.28	-44.0%	USD/shares	10-Q	2024-05-09
Quarterly	2023-06-30	0.28	+0.0%	USD/shares	10-Q	2024-08-09
Quarterly	2023-09-30	0.47	+67.9%	USD/shares	10-Q	2024-11-12
Quarterly	2024-03-31	0.31	-34.0%	USD/shares	10-Q	2025-05-09
Quarterly	2024-06-30	0.4	+29.0%	USD/shares	10-Q	2025-08-07
Quarterly	2024-09-30	0.33	-17.5%	USD/shares	10-Q	2025-11-10
Quarterly	2025-03-31	0.14	-57.6%	USD/shares	10-Q	2025-05-09
Quarterly	2025-06-30	0.19	+35.7%	USD/shares	10-Q	2025-08-07
Quarterly	2025-09-30	0.01	-94.7%	USD/shares	10-Q	2025-11-10
Annual	2016-12-31	0.41	—	USD/shares	10-K	2018-04-02
Annual	2017-12-31	0.9	+119.5%	USD/shares	10-K	2020-03-16
Annual	2018-12-31	0.29	-67.8%	USD/shares	10-K	2021-03-15
Annual	2019-12-31	0.39	+34.5%	USD/shares	10-K	2022-02-28
Annual	2020-12-31	1.01	+159.0%	USD/shares	10-K/A	2023-08-09
Annual	2021-12-31	1.52	+50.5%	USD/shares	10-K	2024-02-29
Annual	2022-12-31	0.99	-34.9%	USD/shares	10-K	2025-03-14
Annual	2023-12-31	1.29	+30.3%	USD/shares	10-K	2026-03-12
Annual	2024-12-31	0.9	-30.2%	USD/shares	10-K	2026-03-12
Annual	2025-12-31	0.46	-48.9%	USD/shares	10-K	2026-03-12

Balance Sheet

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2018-12-31	0.0	—	USD	10-Q	2019-11-08
Quarterly	2019-09-30	234149063.0	—	USD	10-Q	2019-11-08
Quarterly	2019-12-31	232172000.0	-0.8%	USD	10-Q	2020-11-09
Quarterly	2020-03-31	230105000.0	-0.9%	USD	10-Q	2020-05-29
Quarterly	2020-06-30	230455000.0	+0.2%	USD	10-Q	2020-08-10
Quarterly	2020-09-30	226051000.0	-1.9%	USD	10-Q	2020-11-09
Quarterly	2020-12-31	230211000.0	+1.8%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	226937000.0	-1.4%	USD	10-Q	2021-05-07
Quarterly	2021-06-30	182705000.0	-19.5%	USD	10-Q	2021-08-06
Quarterly	2021-09-30	182813000.0	+0.1%	USD	10-Q	2021-11-05
Quarterly	2021-12-31	182917000.0	+0.1%	USD	10-Q	2022-11-07
Quarterly	2022-03-31	183101000.0	+0.1%	USD	10-Q	2022-05-10
Quarterly	2022-06-30	199068000.0	+8.7%	USD	10-Q	2022-08-09
Quarterly	2022-09-30	199150000.0	+0.0%	USD	10-Q	2022-11-07
Quarterly	2022-12-31	203389000.0	+2.1%	USD	10-Q	2023-11-09
Quarterly	2023-03-31	204944000.0	+0.8%	USD	10-Q/A	2023-08-09
Quarterly	2023-06-30	205136000.0	+0.1%	USD	10-Q	2023-08-09
Quarterly	2023-09-30	206213000.0	+0.5%	USD	10-Q	2023-11-09
Quarterly	2023-12-31	258939000.0	+25.6%	USD	10-Q	2024-11-12
Quarterly	2024-03-31	368448000.0	+42.3%	USD	10-Q	2024-05-09
Quarterly	2024-06-30	425006000.0	+15.4%	USD	10-Q	2024-08-09
Quarterly	2024-09-30	423119000.0	-0.4%	USD	10-Q	2024-11-12
Quarterly	2024-12-31	425299000.0	+0.5%	USD	10-Q	2025-11-10
Quarterly	2025-03-31	403894000.0	-5.0%	USD	10-Q	2025-05-09
Quarterly	2025-06-30	401057000.0	-0.7%	USD	10-Q	2025-08-07
Quarterly	2025-09-30	1002026000.0	+149.8%	USD	10-Q	2025-11-10
Annual	2018-12-31	0.0	—	USD	10-K	2020-03-16
Annual	2019-12-31	232172000.0	—	USD	10-K	2021-03-15
Annual	2020-12-31	230211000.0	-0.8%	USD	10-K	2022-02-28
Annual	2021-12-31	182917000.0	-20.5%	USD	10-K/A	2023-08-09
Annual	2022-12-31	203389000.0	+11.2%	USD	10-K	2024-02-29
Annual	2023-12-31	258939000.0	+27.3%	USD	10-K	2025-03-14
Annual	2024-12-31	425299000.0	+64.2%	USD	10-K	2026-03-12
Annual	2025-12-31	990904000.0	+133.0%	USD	10-K	2026-03-12

Cash Flow

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-06-30	163511.0	—	USD	10-Q	2017-08-14
Quarterly	2016-09-30	205775.0	+25.8%	USD	10-Q	2017-11-14
Quarterly	2016-12-31	259551.0	+26.1%	USD	10-Q	2017-02-14
Quarterly	2017-03-31	318821.0	+22.8%	USD	10-Q	2018-05-15
Quarterly	2017-06-30	943395.0	+195.9%	USD	10-Q	2018-08-14
Quarterly	2017-09-30	1627760.0	+72.5%	USD	10-Q	2018-11-14
Quarterly	2018-03-31	485121.0	-70.2%	USD	10-Q	2019-05-10
Quarterly	2018-06-30	682712.0	+40.7%	USD	10-Q	2019-08-09
Quarterly	2018-09-30	867732.0	+27.1%	USD	10-Q	2019-11-08
Quarterly	2019-03-31	104000.0	-88.0%	USD	10-Q	2020-05-29
Quarterly	2019-06-30	378000.0	+263.5%	USD	10-Q	2020-08-10
Quarterly	2019-09-30	807000.0	+113.5%	USD	10-Q	2020-11-09
Quarterly	2020-03-31	269000.0	-66.7%	USD	10-Q	2021-05-07
Quarterly	2020-06-30	451000.0	+67.7%	USD	10-Q	2021-08-06
Quarterly	2020-09-30	553000.0	+22.6%	USD	10-Q	2021-11-05
Quarterly	2021-03-31	98000.0	-82.3%	USD	10-Q	2022-05-10
Quarterly	2021-06-30	7364000.0	+7414.3%	USD	10-Q	2022-08-09
Quarterly	2021-09-30	16420000.0	+123.0%	USD	10-Q	2022-11-07
Quarterly	2022-03-31	17489000.0	+6.5%	USD	10-Q/A	2023-08-09
Quarterly	2022-06-30	18845000.0	+7.8%	USD	10-Q	2023-08-09
Quarterly	2022-09-30	22054000.0	+17.0%	USD	10-Q	2023-11-09
Quarterly	2023-03-31	6027000.0	-72.7%	USD	10-Q	2024-05-09
Quarterly	2023-06-30	17367000.0	+188.2%	USD	10-Q	2024-08-09
Quarterly	2023-09-30	21472000.0	+23.6%	USD	10-Q	2024-11-12
Quarterly	2024-03-31	369000.0	-98.3%	USD	10-Q	2025-05-09
Quarterly	2024-06-30	3205000.0	+768.6%	USD	10-Q	2025-08-07
Quarterly	2024-09-30	5500000.0	+71.6%	USD	10-Q	2025-11-10
Quarterly	2025-03-31	3070000.0	-44.2%	USD	10-Q	2025-05-09
Quarterly	2025-06-30	4490000.0	+46.3%	USD	10-Q	2025-08-07
Quarterly	2025-09-30	7042000.0	+56.8%	USD	10-Q	2025-11-10
Annual	2016-12-31	3306294.0	—	USD	10-K	2018-04-02
Annual	2017-12-31	2084770.0	-36.9%	USD	10-K	2020-03-16
Annual	2018-12-31	1170000.0	-43.9%	USD	10-K	2021-03-15
Annual	2019-12-31	1042000.0	-10.9%	USD	10-K	2022-02-28
Annual	2020-12-31	1164000.0	+11.7%	USD	10-K/A	2023-08-09
Annual	2021-12-31	19223000.0	+1551.5%	USD	10-K	2024-02-29
Annual	2022-12-31	22940000.0	+19.3%	USD	10-K	2025-03-14
Annual	2023-12-31	28529000.0	+24.4%	USD	10-K	2026-03-12
Annual	2024-12-31	8031000.0	-71.8%	USD	10-K	2026-03-12
Annual	2025-12-31	10106000.0	+25.8%	USD	10-K	2026-03-12

Share Data

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-06-30	5914826.0	—	shares	10-Q	2017-08-14
Quarterly	2016-09-30	6024605.0	+1.9%	shares	10-Q	2017-11-14
Quarterly	2016-12-31	6033518.0	+0.1%	shares	10-Q	2017-02-14
Quarterly	2017-03-31	28445647.0	+371.5%	shares	10-Q	2018-05-15
Quarterly	2017-06-30	28417877.0	-0.1%	shares	10-Q	2018-08-14
Quarterly	2017-09-30	28417877.0	+0.0%	shares	10-Q	2018-11-14
Quarterly	2018-03-31	38098373.0	+34.1%	shares	10-Q	2019-05-10
Quarterly	2018-06-30	37850679.0	-0.7%	shares	10-Q	2019-08-09
Quarterly	2018-09-30	38387700.0	+1.4%	shares	10-Q	2019-11-08
Quarterly	2019-03-31	38074174.0	-0.8%	shares	10-Q	2020-05-29
Quarterly	2019-06-30	37962555.0	-0.3%	shares	10-Q	2020-08-10
Quarterly	2019-09-30	37792266.0	-0.4%	shares	10-Q	2020-11-09
Quarterly	2020-03-31	37439099.0	-0.9%	shares	10-Q	2021-05-07
Quarterly	2020-06-30	37285585.0	-0.4%	shares	10-Q	2021-08-06
Quarterly	2020-09-30	37551740.0	+0.7%	shares	10-Q	2021-11-05
Quarterly	2021-03-31	43566189.0	+16.0%	shares	10-Q	2022-05-10
Quarterly	2021-06-30	45828802.0	+5.2%	shares	10-Q	2022-08-09
Quarterly	2021-09-30	46273640.0	+1.0%	shares	10-Q	2022-11-07
Quarterly	2022-03-31	45994868.0	-0.6%	shares	10-Q/A	2023-08-09
Quarterly	2022-06-30	46023015.0	+0.1%	shares	10-Q	2023-08-09
Quarterly	2022-09-30	46152536.0	+0.3%	shares	10-Q	2023-11-09
Quarterly	2023-03-31	46954687.0	+1.7%	shares	10-Q	2024-05-09
Quarterly	2023-06-30	46778299.0	-0.4%	shares	10-Q	2024-08-09
Quarterly	2023-09-30	46920607.0	+0.3%	shares	10-Q	2024-11-12
Quarterly	2024-03-31	47699537.0	+1.7%	shares	10-Q	2025-05-09
Quarterly	2024-06-30	47978491.0	+0.6%	shares	10-Q	2025-08-07
Quarterly	2024-09-30	48223788.0	+0.5%	shares	10-Q	2025-11-10
Quarterly	2025-03-31	48850666.0	+1.3%	shares	10-Q	2025-05-09
Quarterly	2025-06-30	49470677.0	+1.3%	shares	10-Q	2025-08-07
Quarterly	2025-09-30	49473417.0	+0.0%	shares	10-Q	2025-11-10
Annual	2016-12-31	27970431.0	—	shares	10-K	2018-04-02
Annual	2017-12-31	28661735.0	+2.5%	shares	10-K	2020-03-16
Annual	2018-12-31	37914886.0	+32.3%	shares	10-K	2021-03-15
Annual	2019-12-31	36403279.0	-4.0%	shares	10-K	2022-02-28
Annual	2020-12-31	37448430.0	+2.9%	shares	10-K/A	2023-08-09
Annual	2021-12-31	45403085.0	+21.2%	shares	10-K	2024-02-29
Annual	2022-12-31	45602415.0	+0.4%	shares	10-K	2025-03-14
Annual	2023-12-31	46943140.0	+2.9%	shares	10-K	2026-03-12
Annual	2024-12-31	47974334.0	+2.2%	shares	10-K	2026-03-12
Annual	2025-12-31	49369685.0	+2.9%	shares	10-K	2026-03-12

Credit and Bond Coverage

Company-level

Long-Term Debt (latest annual)

990,904,000

Total Liabilities (latest annual)

1,660,327,000

Current Liabilities (latest annual)

615,273,000

Metrics

Frequency	Period End	Value	% Chg	Unit	Form	Filed
Quarterly	2016-06-30	-1.7850	—	ratio	10-Q	2017-08-14
Quarterly	2016-09-30	1.1482	+164.3%	ratio	10-Q	2017-11-14
Quarterly	2016-12-31	-0.2605	-122.7%	ratio	10-Q	2017-02-14
Quarterly	2017-03-31	43.3623	+16743.0%	ratio	10-Q	2018-05-15
Quarterly	2017-06-30	-0.4089	-100.9%	ratio	10-Q	2018-08-14
Quarterly	2017-09-30	-1.6217	-296.6%	ratio	10-Q	2018-11-14
Quarterly	2018-03-31	0.0922	+105.7%	ratio	10-Q	2019-05-10
Quarterly	2018-06-30	0.0450	-51.2%	ratio	10-Q	2019-08-09
Quarterly	2018-09-30	0.2086	+363.7%	ratio	10-Q	2019-11-08
Quarterly	2019-03-31	-0.0134	-106.4%	ratio	10-Q	2020-05-29
Quarterly	2019-06-30	0.0573	+526.6%	ratio	10-Q	2020-08-10
Quarterly	2019-09-30	0.0559	-2.5%	ratio	10-Q	2020-11-09
Quarterly	2020-03-31	0.0151	-73.0%	ratio	10-Q	2021-05-07
Quarterly	2020-06-30	0.3897	+2482.8%	ratio	10-Q	2021-08-06
Quarterly	2020-09-30	0.1108	-71.6%	ratio	10-Q	2021-11-05
Quarterly	2021-03-31	0.0413	-62.7%	ratio	10-Q	2022-05-10
Quarterly	2021-06-30	0.1471	+255.9%	ratio	10-Q	2022-08-09
Quarterly	2021-09-30	-0.0122	-108.3%	ratio	10-Q	2022-11-07
Quarterly	2022-03-31	0.0242	+298.1%	ratio	10-Q/A	2023-08-09
Quarterly	2022-06-30	0.0235	-2.9%	ratio	10-Q	2023-08-09
Quarterly	2022-09-30	0.0474	+101.5%	ratio	10-Q	2023-11-09
Quarterly	2023-03-31	0.0227	-52.2%	ratio	10-Q	2024-05-09
Quarterly	2023-06-30	0.0307	+35.4%	ratio	10-Q	2024-08-09
Quarterly	2023-09-30	0.0468	+52.5%	ratio	10-Q	2024-11-12
Quarterly	2024-03-31	0.0256	-45.2%	ratio	10-Q	2025-05-09
Quarterly	2024-06-30	0.0320	+24.9%	ratio	10-Q	2025-08-07
Quarterly	2024-09-30	0.0267	-16.4%	ratio	10-Q	2025-11-10
Quarterly	2025-03-31	0.0083	-69.0%	ratio	10-Q	2025-05-09
Quarterly	2025-06-30	0.0132	+59.7%	ratio	10-Q	2025-08-07
Quarterly	2025-09-30	0.0014	-89.7%	ratio	10-Q	2025-11-10
Annual	2016-12-31	0.1144	—	ratio	10-K	2018-04-02
Annual	2017-12-31	0.2791	+144.0%	ratio	10-K	2020-03-16
Annual	2018-12-31	0.3320	+18.9%	ratio	10-K	2021-03-15
Annual	2019-12-31	0.0919	-72.3%	ratio	10-K	2022-02-28
Annual	2020-12-31	0.3706	+303.3%	ratio	10-K/A	2023-08-09
Annual	2021-12-31	0.1014	-72.6%	ratio	10-K	2024-02-29
Annual	2022-12-31	0.0840	-17.1%	ratio	10-K	2025-03-14
Annual	2023-12-31	0.0938	+11.6%	ratio	10-K	2026-03-12
Annual	2024-12-31	0.0697	-25.7%	ratio	10-K	2026-03-12
Annual	2025-12-31	0.0303	-56.4%	ratio	10-K	2026-03-12

8-K Material Event Details

104 filings · 224 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

303 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value X-axis date:

All Transactions

Date	Insider	Title	Type	Security	Shares	Price	Total Value	Post-Tx Shares
2026-04-06	Lam Thomas S.	Dir	Equity grant / award A	Common Stock	41,667	$0.00	$0	465,657
2026-04-02	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	2,092	$25.05	$52,405	171,635
2026-04-01	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	57,980	$24.51	$1,421,090	177,655
2026-04-01	Kumar Dinesh M.	Chief Medical Officer	Equity grant / award A	Common Stock	35,300	$0.00	$0	235,635
2026-03-26	Sobotka Glenn	Chief Accounting Officer	Other disposed transaction F	Common Stock	662	$24.27	$16,067	14,039
2026-03-05	Lam Thomas S.	Dir	Other disposed transaction F	Common Stock	9,266	$25.07	$232,299	423,990
2026-02-02	Sim Brandon	CEO and President	Exercise / conversion M · derivative	Stock Option (right to buy)	21,334	$0.00	$0	0
2026-02-02	Sim Brandon	CEO and President	Exercise / conversion M	Common Stock	21,334	$23.24	$495,802	1,045,329
2026-01-23	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	10,759	$27.16	$292,214	202,032
2026-01-13	Schmidt David	Dir	Exercise / conversion M · derivative	Stock Option (right to Buy)	20,000	$0.00	$0	0
2026-01-13	Schmidt David	Dir	Other disposed transaction F	Common Stock	4,269	$27.12	$115,775	31,494
2026-01-13	Schmidt David	Dir	Exercise / conversion M	Common Stock	20,000	$5.79	$115,800	35,763
2026-01-01	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	5,102	$24.81	$126,581	212,791
2025-12-08	Lam Thomas S.	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	29,502	$0.00	$0	0
2025-12-08	Lam Thomas S.	Dir	Other disposed transaction F	Common Stock	25,866	$22.00	$569,052	433,256
2025-12-08	Lam Thomas S.	Dir	Exercise / conversion M	Common Stock	29,502	$17.78	$524,546	459,122
2025-11-10	Sim Kenneth T.	Executive Chairman	Exercise / conversion M · derivative	Stock Option (right to buy)	29,502	$0.00	$0	0
2025-11-10	Sim Kenneth T.	Executive Chairman	Exercise / conversion M	Common Stock	29,502	$17.78	$524,546	639,407
2025-11-07	Kitayama Mitchell W	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	12,000	$0.00	$0	0
2025-11-07	Kitayama Mitchell W	Dir	Exercise / conversion M	Common Stock	12,000	$18.20	$218,400	27,846
2025-11-03	Marsh Linda	Dir	Exercise / conversion M · derivative	Stock Option (right to Buy)	20,000	$0.00	$0	0
2025-11-03	Marsh Linda	Dir	Other disposed transaction F	Common Stock	11,033	$32.99	$363,979	92,608
2025-11-03	Marsh Linda	Dir	Exercise / conversion M	Common Stock	20,000	$18.20	$364,000	103,641
2025-10-02	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	1,979	$27.77	$54,957	174,967
2025-09-15	Kitayama Mitchell W	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	8,000	$0.00	$0	12,000
2025-09-15	Kitayama Mitchell W	Dir	Other disposed transaction D	Common Stock	5,214	$30.23	$157,619	15,846
2025-09-15	Kitayama Mitchell W	Dir	Other disposed transaction D	Common Stock	8,000	$30.23	$241,840	21,060
2025-09-15	Kitayama Mitchell W	Dir	Exercise / conversion M	Common Stock	8,000	$18.20	$145,600	29,060
2025-09-05	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	1,694	$29.70	$50,312	176,946
2025-09-02	Schmidt David	Dir	Exercise / conversion M · derivative	Stock Option (right to Buy)	20,000	$0.00	$0	0
2025-09-02	Schmidt David	Dir	Other disposed transaction D	Common Stock	20,000	$27.76	$555,200	15,763
2025-09-02	Schmidt David	Dir	Exercise / conversion M	Common Stock	20,000	$18.20	$364,000	35,763
2025-08-13	Chiang John	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	20,000	$0.00	$0	0
2025-08-13	Chiang John	Dir	Other disposed transaction F	Common Stock	12,284	$29.63	$363,975	30,848
2025-08-13	Chiang John	Dir	Exercise / conversion M	Common Stock	20,000	$18.20	$364,000	43,132
2025-07-01	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	6,831	$25.06	$171,185	218,811
2025-06-11	Mazdyasni Matthew	Dir	Equity grant / award A	Common Stock	6,449	$0.00	$0	14,763
2025-06-04	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	1,656	$25.06	$41,499	225,642
2025-05-16	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	10,035	$27.18	$272,751	178,640
2025-04-29	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	828	$31.15	$25,792	227,298
2025-04-14	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	2,683	$34.05	$91,356	188,675
2025-04-02	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	1,394	$30.02	$41,848	191,358
2025-03-26	Sobotka Glenn	Chief Accounting Officer	Equity grant / award A	Common Stock	8,269	$0.00	$0	14,701
2025-03-26	Sobotka Glenn	Chief Accounting Officer	Equity grant / award A	Common Stock	6,432	$0.00	$0	6,432
2025-03-05	Sim Brandon	CEO and President	Other disposed transaction F	Common Stock	105,795	$27.19	$2,876,566	1,023,219
2025-03-05	Sim Brandon	CEO and President	Equity grant / award A	Common Stock	145,642	$0.00	$0	1,129,014
2025-02-15	Sim Kenneth T.	Executive Chairman	Other acquired transaction J	Common Stock	26,232	$0.00	$0	546,349
2025-02-15	Sim Kenneth T.	Executive Chairman	Other disposed transaction J	Common Stock	699,896	$0.00	$0	6,132,802
2025-01-23	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	7,210	$37.96	$273,692	209,291
2025-01-17	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp	10%	Other disposed transaction D	Common Stock	300,000	$35.17	$10,551,000	6,832,698
2025-01-01	Kumar Dinesh M.	Chief Medical Officer	Other disposed transaction F	Common Stock	967	$31.53	$30,490	215,872
2024-12-10	Kitayama Mitchell W	Dir	Other disposed transaction D	Common Stock	5,100	$43.09	$219,759	14,611
2024-11-30	Vong John	Chief Accounting Officer	Other disposed transaction F	Common Stock	134	$43.25	$5,796	17,520
2024-11-22	Kitayama Mitchell W	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	3,409	$0.00	$0	0
2024-11-22	Kitayama Mitchell W	Dir	Other disposed transaction F	Common Stock	1,490	$42.11	$62,744	19,711
2024-11-22	Kitayama Mitchell W	Dir	Exercise / conversion M	Common Stock	3,409	$18.41	$62,760	21,201
2024-11-19	Chiang John	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	1,515	$0.00	$0	0
2024-11-19	Chiang John	Dir	Other disposed transaction F	Common Stock	681	$40.93	$27,873	16,683
2024-11-19	Chiang John	Dir	Exercise / conversion M	Common Stock	1,515	$18.41	$27,891	17,364
2024-11-18	Sim Kenneth T.	Executive Chairman	Exercise / conversion M · derivative	Stock option (right to buy)	28,046	$0.00	$0	0
2024-11-18	Sim Kenneth T.	Executive Chairman	Exercise / conversion M	Common Stock	28,046	$18.65	$523,058	609,905
2024-11-12	Vong John	Chief Accounting Officer	Other disposed transaction F	Common Stock	636	$42.91	$27,291	17,654
2024-11-08	Kumar Dinesh M.	See remarks	Equity grant / award A	Common Stock	67,238	$0.00	$0	216,839
2024-10-02	Sim Brandon	CEO and President	Other disposed transaction F	Common Stock	2,626	$57.87	$151,967	948,986
2024-09-10	Marsh Linda	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	11,000	$0.00	$0	0
2024-09-10	Marsh Linda	Dir	Other disposed transaction F	Common Stock	3,522	$47.93	$168,809	77,192
2024-09-10	Marsh Linda	Dir	Exercise / conversion M	Common Stock	11,000	$15.35	$168,850	80,714
2024-09-09	Lam Thomas S.	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	28,046	$0.00	$0	0
2024-09-09	Lam Thomas S.	Dir	Other disposed transaction F	Common Stock	11,046	$47.35	$523,028	398,855
2024-09-09	Lam Thomas S.	Dir	Exercise / conversion M	Common Stock	28,046	$18.65	$523,058	409,901
2024-08-16	Schmidt David	Dir	Other disposed transaction D	Common Stock	14,409	$49.76	$716,992	9,314
2024-08-14	Schmidt David	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	3,409	$0.00	$0	0
2024-08-14	Schmidt David	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	11,000	$0.00	$0	0
2024-08-14	Schmidt David	Dir	Exercise / conversion M	Common Stock	3,409	$18.41	$62,760	23,723
2024-08-14	Schmidt David	Dir	Exercise / conversion M	Common Stock	11,000	$15.35	$168,850	20,314
2024-08-13	Marsh Linda	Dir	Equity grant / award A	Common Stock	3,564	$0.00	$0	69,714
2024-08-01	Kumar Dinesh M.	See remarks	Other disposed transaction F	Common Stock	794	$51.57	$40,947	149,601
2024-07-11	Vong John	Chief Accounting Officer	Other disposed transaction F	Common Stock	336	$45.00	$15,120	18,357
2024-05-16	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	7,051	$41.13	$290,008	151,232
2024-05-12	Vong John	Chief Accounting Officer	Other disposed transaction F	Common Stock	636	$38.89	$24,734	18,617
2024-04-14	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	7,993	$40.72	$325,475	158,283
2024-04-02	Basho Chandan	CFO and COO	Equity grant / award A	Common Stock	15,692	$0.00	$0	172,783
2024-03-29	Basho Chandan	COO and CFO	Other disposed transaction F	Common Stock	6,507	$41.99	$273,229	166,276
2024-01-23	Kumar Dinesh M.	See remarks	Equity grant / award A	Common Stock	6,527	$0.00	$0	150,395
2024-01-23	Kumar Dinesh M.	See remarks	Equity grant / award A	Common Stock	13,053	$0.00	$0	143,868
2024-01-23	Kumar Dinesh M.	See remarks	Equity grant / award A	Common Stock	16,316	$0.00	$0	117,762
2024-01-23	Kumar Dinesh M.	See remarks	Equity grant / award A	Common Stock	85,130	$0.00	$0	85,130
2023-12-15	Vong John	Chief Accounting Officer	Equity grant / award A	Common Stock	7,100	$0.00	$0	19,253
2023-12-15	Vong John	Chief Accounting Officer	Equity grant / award A	Common Stock	1,813	$0.00	$0	12,153
2023-12-06	Schmidt David	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	7,500	$0.00	$0	0
2023-12-06	Schmidt David	Dir	Other disposed transaction D	Common Stock	7,500	$33.49	$251,175	0
2023-12-06	Schmidt David	Dir	Exercise / conversion M	Common Stock	7,500	$18.11	$135,825	7,500
2023-11-30	Vong John	Chief Accounting Officer	Other disposed transaction F	Common Stock	65	$33.23	$2,160	4,901
2023-11-14	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Other disposed transaction D	Common Stock	3,166,561	$31.58	$99,999,996	7,132,698
2023-07-11	Vong John	Chief Accounting Officer	Other disposed transaction F	Common Stock	325	$32.07	$10,423	4,966
2023-07-01	Vong John	Chief Accounting Officer	Other disposed transaction D	Common Stock	1,520	$0.00	$0	5,291
2023-05-16	Basho Chandan	See Remarks	Equity grant / award A	Common Stock	60,803	$0.00	$0	157,091
2023-05-16	Basho Chandan	See Remarks	Equity grant / award A	Common Stock	60,808	$0.00	$0	96,288
2023-05-16	Basho Chandan	See Remarks	Equity grant / award A	Common Stock	9,121	$0.00	$0	35,480
2023-05-16	Basho Chandan	See Remarks	Other disposed transaction D	Common Stock	48,086	$0.00	$0	26,359
2023-05-16	Vong John	Chief Accounting Officer	Equity grant / award A	Common Stock	760	$0.00	$0	8,331
2023-05-16	Vong John	Chief Accounting Officer	Equity grant / award A	Common Stock	1,520	$0.00	$0	6,811
2023-05-16	Vong John	Chief Accounting Officer	Other disposed transaction D	Common Stock	4,164	$0.00	$0	3,771
2023-04-14	Basho Chandan	See Remarks	Other disposed transaction F	Common Stock	2,494	$39.06	$97,416	74,445
2023-03-14	Marsh Linda	Dir	Other disposed transaction D	Common Stock	270,081	$35.32	$9,539,261	0
2023-03-09	Marsh Linda	Dir	Exercise / conversion M · derivative	Stock Option (right to buy)	62,500	$0.00	$0	0
2023-03-09	Marsh Linda	Dir	Exercise / conversion M	Common Stock	62,500	$10.00	$625,000	62,500
2022-12-12	Vong John	SVP-Chief Accounting Officer	Equity grant / award A	Common Stock	694	$0.00	$0	7,935
2022-12-12	Vong John	SVP-Chief Accounting Officer	Equity grant / award A	Common Stock	1,388	$0.00	$0	6,547
2022-12-08	Sim Kenneth T.	Executive Chairman	Exercise / conversion M · derivative	Warrants to purchase Common Stock	48,587	—	$534,458	0
2022-12-08	Sim Kenneth T.	Executive Chairman	Exercise / conversion M · derivative	Warrants to purchase Common Stock	51,445	—	$514,452	0
2022-12-08	Sim Kenneth T.	Executive Chairman	Exercise / conversion M	Common Stock	48,587	$11.00	$534,457	291,859
2022-12-08	Sim Kenneth T.	Executive Chairman	Exercise / conversion M	Common Stock	51,445	$10.00	$514,450	243,272
2022-12-07	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion M · derivative	Warrants to purchase Common Stock	52,263	—	$574,891	0
2022-12-07	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion M · derivative	Warrants to purchase Common Stock	55,337	—	$553,371	0
2022-12-07	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion M	Common Stock	52,262	$11.00	$574,882	10,299,259
2022-12-07	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion M	Common Stock	55,337	$10.00	$553,370	10,246,997
2022-12-05	Lam Thomas S.	President and Co-CEO	Exercise / conversion M · derivative	Warrants to purchase Common Stock	48,586	—	$534,444	0
2022-12-05	Lam Thomas S.	President and Co-CEO	Exercise / conversion M · derivative	Warrants to purchase Common Stock	51,443	—	$514,428	0
2022-12-05	Lam Thomas S.	President and Co-CEO	Exercise / conversion M	Common Stock	48,585	$11.00	$534,435	291,855
2022-12-05	Lam Thomas S.	President and Co-CEO	Exercise / conversion M	Common Stock	51,443	$10.00	$514,430	243,270
2022-12-02	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Other disposed transaction J	Common Stock	984,042	$0.00	$0	10,191,660
2022-11-29	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M · derivative	Warrants to purchase Common Stock	26,828	—	$295,108	0
2022-11-29	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M · derivative	Warrants to purchase Common Stock	28,406	—	$284,061	0
2022-11-29	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M	Common Stock	26,828	$11.00	$295,108	1,165,243
2022-11-29	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M	Common Stock	28,406	$10.00	$284,060	1,138,415
2022-11-04	Sim Brandon	Co-Chief Executive Officer	Equity grant / award A	Common Stock	20,320	$0.00	$0	522,567
2022-11-04	Sim Brandon	Co-Chief Executive Officer	Equity grant / award A	Common Stock	11,113	$0.00	$0	502,247
2022-09-27	Sim Brandon	Co-CEO	Equity grant / award G	Common Stock	392,816	$0.00	$0	392,816
2022-09-27	Lam Thomas S.	President and Co-CEO	Equity grant / award G	Common Stock	383,764	$0.00	$0	0
2022-06-27	Sim Brandon	Co- Chief Executive Officer	Equity grant / award A	Common Stock	198,511	$0.00	$0	491,134
2022-06-27	Sim Brandon	Co- Chief Executive Officer	Equity grant / award A	Common Stock	108,560	$0.00	$0	292,623
2022-06-17	Marsh Linda	Dir	Open-market sell S	Common Stock	250,000	$37.00	$9,250,000	270,081
2022-03-31	Chin Eric	Chief Financial Officer	Other disposed transaction F	Common Stock	469	$48.47	$22,732	20,844
2022-03-03	Lam Thomas S.	President and Co-CEO	Equity grant / award G	Common Stock	200,000	$0.00	$0	799,855
2022-02-25	Sim Brandon	Co-CEO	Equity grant / award G	Common Stock	258,824	$0.00	$0	258,824
2022-02-03	Chin Eric	Chief Financial Officer	Other disposed transaction F	Common Stock	2,802	$50.71	$142,089	21,313
2022-01-20	Mazdyasni Matthew	Dir	Equity grant / award A · derivative	Stock Option (right to buy)	8,500	$0.00	$0	8,500
2021-11-04	Sim Kenneth T.	Executive Chairman	Equity grant / award G	Common Stock	230,688	$0.00	$0	397,724
2021-11-02	Lam Thomas S.	President and Co-CEO	Equity grant / award A · derivative	Stock Option (right to buy)	29,502	$0.00	$0	29,502
2021-11-02	Lam Thomas S.	President and Co-CEO	Equity grant / award A	Common Stock	65,242	$0.00	$0	191,827
2021-08-17	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	40,000	$73.67	$2,946,800	10,925,702
2021-06-22	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Other disposed transaction J	Common Stock	1,862	$0.00	$0	10,885,732
2021-06-22	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Other disposed transaction J	Common Stock	1,892	$0.00	$0	10,885,702
2021-06-15	Young Albert WaiChow	Chief Administrative Officer	Open-market sell S	Common Stock	5,000	$48.58	$242,900	1,110,265
2021-05-31	Sim Brandon	See Remarks	Other disposed transaction F	Common Stock	5,426	$34.88	$189,259	141,612
2021-05-13	Sim Brandon	See Remarks	Open-market buy P	Common Stock	1,000	$31.40	$31,400	147,038
2021-04-28	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	100,000	$24.50	$2,450,000	10,750,961
2021-04-28	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	100,000	$24.50	$2,450,000	10,887,594
2021-04-01	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market sell S	Common Stock	1,638,045	$24.50	$40,132,102	10,787,594
2021-04-01	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market sell S	Common Stock	1,638,045	$24.50	$40,132,102	10,650,961
2021-03-31	Young Albert WaiChow	Chief Administrative Officer	Other disposed transaction F	Common Stock	256	$27.09	$6,935	1,018,387
2021-03-30	Sim Kenneth T.	Executive Chairman and Co-CEO	Exercise / conversion M	Common Stock	31,756	$10.00	$317,560	859,100
2021-03-30	Sim Kenneth T.	Executive Chairman and Co-CEO	Exercise / conversion M · derivative	Warrant to Purchase Common Stock	31,756	$0.00	$0	0
2021-03-30	Sim Kenneth T.	Executive Chairman and Co-CEO	Exercise / conversion M	Common Stock	31,756	$10.00	$317,560	859,101
2021-03-29	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion X	Common Stock	34,158	$10.00	$341,580	12,425,639
2021-03-29	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion X · derivative	Warrant to Purchase Common Stock	34,158	$0.00	$0	0
2021-03-29	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion X	Common Stock	34,158	$10.00	$341,580	12,289,006
2021-03-08	Sim Brandon	COO, CTO and VP of Engineering	Equity grant / award A	Common Stock	59,165	$0.00	$0	146,038
2021-02-03	Sim Brandon	COO, CTO and VP of Engineering	Equity grant / award A · derivative	Stock Option (right to buy)	21,334	$0.00	$0	21,334
2021-02-03	Sim Brandon	COO, CTO and VP of Engineering	Equity grant / award A	Common Stock	47,210	$0.00	$0	86,873
2020-12-22	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Other disposed transaction J	Common Stock	4,984,050	$0.00	$0	12,391,481
2020-12-22	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Other disposed transaction J	Common Stock	4,984,050	$0.00	$0	12,323,164
2020-12-22	Sim Kenneth T.	Executive Chairman and Co-CEO	Other acquired transaction J	Common Stock	185,938	$0.00	$0	827,344
2020-12-22	Young Albert WaiChow	Chief Administrative Officer	Other acquired transaction J	Common Stock	96,877	$0.00	$0	1,115,265
2020-12-10	Sim Kenneth T.	Executive Chairman and Co-CEO	Equity grant / award A · derivative	Stock Option (right to buy)	29,502	$0.00	$0	29,502
2020-12-10	Sim Kenneth T.	Executive Chairman and Co-CEO	Equity grant / award A	Common Stock	65,242	$0.00	$0	126,585
2020-11-11	Fawcett Mark	Dir	Equity grant / award A · derivative	Stock Option (right to buy)	20,000	$0.00	$0	20,000
2020-09-15	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion X	Common Stock	68,317	$9.00	$614,853	17,375,531
2020-09-15	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion X · derivative	Warrant to Purchase Common Stock	68,317	$0.00	$0	0
2020-09-15	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Exercise / conversion X	Common Stock	68,317	$9.00	$614,853	17,307,214
2020-09-14	Lam Thomas S.	President and Co-CEO	Open-market buy P	Common Stock	5,000	$17.28	$86,381	690,490
2020-09-11	Vazquez Adrian	Chief Medical Officer	Open-market sell S	Common Stock	602	$18.00	$10,836	471,004
2020-09-10	Sim Kenneth T.	Executive Chairman and Co-CEO	Open-market buy P	Common Stock	5,000	$17.60	$88,000	37,996
2020-09-10	Sim Brandon	See Remarks	Open-market buy P	Common Stock	5,000	$17.60	$88,000	37,996
2020-09-09	Lam Thomas S.	President and Co-CEO	Open-market buy P	Common Stock	5,000	$17.85	$89,250	1,814,872
2020-09-09	Sim Kenneth T.	Executive Chairman and Co-CEO	Other acquired transaction J	Common Stock	564,706	$0.00	$0	564,706
2020-09-08	Lam Thomas S.	President and Co-CEO	Exercise / conversion M · derivative	Warrants to Purchase Common Stock	63,510	$0.00	$0	0
2020-09-08	Lam Thomas S.	President and Co-CEO	Other disposed transaction F	Common Stock	30,252	$18.89	$571,460	1,809,872
2020-09-08	Lam Thomas S.	President and Co-CEO	Exercise / conversion M	Common Stock	63,510	$9.00	$571,590	1,840,124
2020-08-27	Sim Brandon	See Remarks	Open-market buy P	Common Stock	5,000	$18.34	$91,700	1,770,556
2020-06-15	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M · derivative	Warrants to Purchase Common Stock	17,534	$0.00	$0	0
2020-06-15	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M · derivative	Warrants to Purchase Common Stock	35,069	$0.00	$0	0
2020-06-15	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M	Common Stock	17,534	$10.00	$175,340	1,018,643
2020-06-15	Young Albert WaiChow	Chief Administrative Officer	Exercise / conversion M	Common Stock	35,069	$9.00	$315,621	1,001,109
2020-06-08	Vazquez Adrian	Chief Medical Officer	Open-market sell S	Common Stock	4,200	$17.09	$71,778	484,873
2020-06-05	Vazquez Adrian	Chief Medical Officer	Open-market sell S	Common Stock	29,185	$17.23	$502,858	489,073
2020-06-03	Vazquez Adrian	Chief Medical Officer	Open-market sell S	Common Stock	2,683	$18.00	$48,294	518,258
2020-05-26	Ang Hing	Chief Operating Officer	Other disposed transaction D	Common Stock	2,444	$0.00	$0	38,316
2020-05-06	Fawcett Mark	Dir	Other disposed transaction D · derivative	Stock Option (right to buy)	20,000	$0.00	$0	36,909
2020-05-06	Fawcett Mark	Dir	Exercise / conversion M	Common Stock	20,000	$5.00	$100,000	30,000
2020-03-31	Young Albert WaiChow	Chief Administrative Officer	Other disposed transaction F	Common Stock	256	$12.92	$3,308	966,040
2020-03-04	Marsh Linda	Dir	Equity grant / award A · derivative	Stock Option (right to buy)	62,500	—	$625,000	62,500
2020-03-04	Marsh Linda	Dir	Other disposed transaction D · derivative	Stock Option (right to buy)	62,500	—	$625,000	0
2020-02-05	Kitayama Mitchell W	Dir	Equity grant / award A · derivative	Stock Option (right to buy)	3,550	$0.00	$0	22,050
2020-02-05	Young Albert WaiChow	Chief Administrative Officer	Equity grant / award A	Common Stock	1,880	$0.00	$0	966,296
2020-01-15	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	4,298	$18.34	$78,825	17,307,214
2020-01-14	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	7,130	$17.81	$126,985	17,302,916
2020-01-13	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	5,469	$17.42	$95,270	17,295,786
2019-12-30	Sim Kenneth T.	Executive Chairman and Co-CEO	Equity grant / award A · derivative	Stock Option (right to buy)	28,046	$0.00	$0	28,046
2019-12-30	Sim Kenneth T.	Executive Chairman and Co-CEO	Equity grant / award A	Common Stock	61,343	$0.00	$0	61,343
2019-12-27	Sim Kenneth T.	Executive Chairman and Co-CEO	Other disposed transaction J · derivative	Stock Option (right to buy)	39,189	$0.00	$0	0
2019-12-27	Sim Kenneth T.	Executive Chairman and Co-CEO	Other disposed transaction J	Common Stock	58,883	$0.00	$0	0
2019-12-18	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	15,000	$18.50	$277,500	17,290,317
2019-12-17	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	15,000	$18.47	$277,050	17,275,317
2019-12-16	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	15,000	$18.94	$284,100	17,260,317
2019-12-13	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	35,718	$18.32	$654,354	17,245,317
2019-12-12	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	23,673	$18.06	$427,534	17,209,599
2019-12-10	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	23,462	$16.75	$392,988	17,064,939
2019-12-09	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	38,600	$17.60	$679,360	17,041,477
2019-12-08	Young Albert WaiChow	Chief Administrative Officer	Equity grant / award A	Common Stock	93,450	$0.00	$0	17,158,389
2019-12-08	Young Albert WaiChow	Chief Administrative Officer	Equity grant / award A	Common Stock	47,970	$0.00	$0	966,301
2019-12-06	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	32,363	$18.95	$613,279	17,002,877
2019-12-05	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	13,595	$18.64	$253,411	16,970,514
2019-12-04	Eng Michael F.	Dir	Open-market buy P	Common Stock	1,890	$18.48	$34,927	4,890
2019-12-03	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	20,000	$18.24	$364,800	16,938,380
2019-12-02	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	18,602	$17.94	$333,720	16,918,380
2019-11-29	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	6,500	$18.46	$119,990	16,899,778
2019-11-27	Ang Hing	Chief Operating Officer	Equity grant / award A	Common Stock	3,674	$0.00	$0	41,267
2019-11-26	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	10,000	$17.96	$179,600	16,890,778
2019-11-25	Fawcett Mark	Dir	Equity grant / award A · derivative	Stock Options	2,048	$0.00	$0	55,548
2019-11-22	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	25,000	$17.79	$444,750	16,847,778
2019-11-21	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	1,900	$17.50	$33,250	16,822,778
2019-11-20	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	12,100	$17.28	$209,088	16,820,878
2019-11-19	ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp	10%	Open-market buy P	Common Stock	18,203	$16.17	$294,343	16,808,778
2019-11-14	Sim Kenneth T.	Executive Chairman and Co-CEO	Open-market buy P	Common Stock	10,000	$14.67	$146,700	1,737,561
2019-10-11	Schmidt David	Dir	Equity grant / award A · derivative	Stock Options	11,000	$0.00	$0	98,500
2019-10-08	Sim Kenneth T.	Executive Chairman and Co-CEO	Open-market buy P	Common Stock	5,000	$15.55	$77,750	1,727,561
2019-09-30	Lam Thomas S.	Co-Chief Executive Officer	Equity grant / award A · derivative	Stock Option (right to buy)	39,189	$0.00	$0	39,189
2019-09-30	Lam Thomas S.	Co-Chief Executive Officer	Equity grant / award A	Common Stock	58,883	$0.00	$0	58,883
2019-09-13	Vazquez Adrian	Chief Medical Officer	Open-market sell S	Common Stock	27,350	$19.77	$540,710	520,941
2019-09-12	Vazquez Adrian	Chief Medical Officer	Open-market sell S	Common Stock	13,746	$20.14	$276,844	548,291
2019-09-12	Eng Michael F.	Dir	Open-market buy P	Common Stock	2,000	$20.28	$40,560	3,000
2019-09-11	Vazquez Adrian	Chief Medical Officer	Open-market sell S	Common Stock	43,704	$20.14	$880,199	562,037
2019-08-19	Eng Michael F.	Dir	Open-market buy P	Common Stock	1,000	$15.97	$15,970	1,000
2019-08-14	Young Albert WaiChow	Co-Chief Medical Officer	Open-market buy P	Common Stock	5,000	$15.01	$75,050	916,446
2019-06-14	Chiang John	Dir	Open-market buy P	Common Stock	100	$16.31	$1,631	100
2019-06-12	Chin Eric	Chief Financial Officer	Open-market buy P	Common Stock	2,040	$14.72	$30,029	3,639
2019-06-11	Fawcett Mark	Dir	Open-market buy P	Common Stock	10,000	$14.13	$141,300	10,000
2019-06-04	Vazquez Adrian	Co-Chief Medical Officer	Open-market sell S	Common Stock	38,051	$16.01	$609,056	605,741
2019-06-03	Vazquez Adrian	Co-Chief Medical Officer	Open-market sell S	Common Stock	46,949	$16.64	$781,114	643,792
2019-01-30	Chin Eric	Chief Financial Officer	Equity grant / award A	Common Stock	1,599	$0.00	$0	1,599
2019-01-11	Yu Li	Dir	Equity grant / award A · derivative	Stock Options	7,500	$0.00	$0	7,500
2019-01-11	Fawcett Mark	Dir	Equity grant / award A · derivative	Options	7,500	$0.00	$0	7,500
2018-12-08	Young Albert WaiChow	Co-Chief Medical Officer	Equity grant / award A	Common Stock	93,451	$0.00	$0	1,775,560
2018-12-08	Young Albert WaiChow	Co-Chief Medical Officer	Equity grant / award A	Common Stock	47,971	$0.00	$0	911,446
2018-11-28	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	35,000	$16.60	$581,000	524,438
2018-11-27	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	30,000	$17.31	$519,300	559,438
2018-11-26	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	20,000	$17.91	$358,200	589,438
2018-11-23	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	20,000	$17.07	$341,400	609,438
2018-11-21	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	30,000	$16.21	$486,300	629,438
2018-11-20	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	20,000	$17.58	$351,600	659,438
2018-11-19	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	20,000	$18.97	$379,400	679,438
2018-09-10	Vazquez Adrian	Co-Chief Medical Officer	Open-market sell S	Common Stock	7,886	$16.01	$126,255	912,338
2018-09-07	Vazquez Adrian	Co-Chief Medical Officer	Open-market sell S	Common Stock	25,688	$15.02	$385,834	920,224
2018-08-30	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	7,900	$15.76	$124,504	699,438
2018-08-29	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	15,000	$16.03	$240,450	707,338
2018-08-27	Vazquez Adrian	Co-Chief Medical Officer	Open-market sell S	Common Stock	25,000	$17.35	$433,750	945,912
2018-08-24	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	15,000	$16.47	$247,050	752,338
2018-08-24	Vazquez Adrian	Co-Chief Medical Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	18,574	$0.00	$0	4,826
2018-08-24	Vazquez Adrian	Co-Chief Medical Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	10,000	$0.00	$0	23,400
2018-08-24	Vazquez Adrian	Co-Chief Medical Officer	Exercise / conversion M · derivative	Stock Option (right to buy)	30,000	$0.00	$0	33,400
2018-08-24	Vazquez Adrian	Co-Chief Medical Officer	Exercise / conversion M	Common Stock	18,574	$6.37	$118,316	970,912
2018-08-24	Vazquez Adrian	Co-Chief Medical Officer	Exercise / conversion M	Common Stock	10,000	$10.00	$100,000	952,338
2018-08-24	Vazquez Adrian	Co-Chief Medical Officer	Exercise / conversion M	Common Stock	30,000	$1.50	$45,000	942,338
2018-08-23	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	18,000	$15.97	$287,460	767,338
2018-08-22	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	15,000	$16.32	$244,800	785,338
2018-08-21	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	15,000	$16.73	$250,950	800,338
2018-08-17	Augusta Gary	Dir	Equity grant / award A	Common Stock	12,948	$18.71	$242,218	152,997
2018-08-17	Augusta Gary	Dir	Open-market sell S	Common Stock	12,948	$18.71	$242,218	152,997
2018-06-14	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	20,000	$16.35	$327,000	837,338
2018-06-13	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	15,000	$15.77	$236,550	857,338
2018-06-12	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	13,000	$15.44	$200,720	872,338
2018-06-11	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	12,000	$15.44	$185,280	885,338
2018-06-08	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	8,000	$14.73	$117,840	897,338
2018-06-07	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	14,535	$14.20	$206,397	905,338
2018-06-06	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	13,876	$14.70	$203,977	919,873
2018-06-05	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	13,876	$14.85	$206,059	933,749
2018-06-04	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	13,876	$14.78	$205,087	947,625
2018-06-01	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	11,876	$14.37	$170,658	961,501
2018-05-31	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	9,476	$13.63	$129,158	973,377
2018-05-30	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$13.28	$78,033	982,853
2018-05-29	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$13.52	$79,444	988,729
2018-05-25	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$13.70	$80,501	994,605
2018-05-24	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$14.19	$83,380	1,000,481
2018-05-23	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$14.69	$86,318	1,006,357
2018-05-22	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$15.39	$90,432	1,012,233
2018-05-21	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$15.66	$92,018	1,018,109
2018-05-18	Hosseinion Warren	Co-Chief Executive Officer	Open-market sell S	Common Stock	5,876	$15.90	$93,428	1,023,985
2018-03-21	Ang Hing	Chief Operating Officer	Equity grant / award A	Common Stock	37,593	$0.00	$0	37,593
2018-01-15	Shah Mihir	Chief Financial Officer	Exercise / conversion M · derivative	Stock Option	23,610	$0.00	$0	26,390
2018-01-15	Shah Mihir	Chief Financial Officer	Other acquired transaction F	Common Stock	3,678	$28.90	$106,294	19,932
2018-01-15	Shah Mihir	Chief Financial Officer	Exercise / conversion M	Common Stock	23,610	$4.50	$106,245	23,610
2018-01-15	Hosseinion Warren	Co-Chief Executive Officer	Exercise / conversion M · derivative	Stock Option	22,476	$0.00	$0	71,024
2018-01-15	Hosseinion Warren	Co-Chief Executive Officer	Other disposed transaction F	Common Stock	4,953	$28.90	$143,142	1,029,861
2018-01-15	Hosseinion Warren	Co-Chief Executive Officer	Exercise / conversion M	Common Stock	22,476	$6.37	$143,172	1,034,814
2017-12-08	Lam Thomas S.	Co-Chief Executive Officer	Other acquired transaction J	Common Stock	1,682,109	—	—	1,682,109
2017-12-08	Lam Thomas S.	Co-Chief Executive Officer	Other acquired transaction J	Common Stock	1,563,763	—	—	1,563,763
2017-04-06	Hosseinion Warren	Chief Executive Officer	Equity grant / award A · derivative	Stock Option (right to buy)	23,363	$0.00	$0	23,363
2017-04-06	Hosseinion Warren	Chief Executive Officer	Equity grant / award A · derivative	Stock Option (right to buy)	6,637	$0.00	$0	6,637
2016-11-14	Shah Mihir	Chief Financial Officer	Equity grant / award A · derivative	Stock Option (right to buy)	50,000	$0.00	$0	50,000
2016-09-14	Fawcett Mark	Dir	Equity grant / award A · derivative	Common Stock	20,000	$0.00	$0	20,000
2016-09-14	Hosseinion Warren	Chief Executive Officer	Equity grant / award A · derivative	Stock Option (right to buy)	93,500	$0.00	$0	93,500

Regulatory Activity

Last 12 months to 2025-04-29

Insider Filings (Forms 3/4/5) — 12 months

Material Event Filings (8-K) — 12 months

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count